Inhibitory effect of receptor for advanced glycation end products (RAGE) on the TGF-β-induced alveolar epithelial to mesenchymal transition

Idiopathic pulmonary fibrosis (IPF) is a lethal parenchymal lung disease characterized by myofibroblast proliferation. Alveolar epithelial cells (AECs) are thought to produce myofibroblasts through the epithelial to mesenchymal transition (EMT). Receptor for advanced glycation end products (RAGE) is...

Full description

Saved in:
Bibliographic Details
Published inExperimental & molecular medicine Vol. 43; no. 9; pp. 517 - 524
Main Authors Song, Jeong Sup, Kang, Chun Mi, Park, Chan Kwon, Yoon, Hyung Kyu, Lee, Sook Young, Ahn, Joong Hyun, Moon, Hwa-Sik
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 30.09.2011
Korean Society for Biochemistry and Molecular Biology
생화학분자생물학회
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Idiopathic pulmonary fibrosis (IPF) is a lethal parenchymal lung disease characterized by myofibroblast proliferation. Alveolar epithelial cells (AECs) are thought to produce myofibroblasts through the epithelial to mesenchymal transition (EMT). Receptor for advanced glycation end products (RAGE) is a member of the immunoglobulin superfamily of cell surface receptors whose activation is associated with renal fibrosis during diabetes and liver fibrosis. RAGE is expressed at low basal levels in most adult tissues except the lung. In this study, we evaluated the interaction of ligand advanced glycation end products (AGE) with RAGE during the epithelial to myofibroblast transition in rat AECs. Our results indicate that AGE inhibited the TGF-β-dependent alveolar EMT by increasing Smad7 expression, and that the effect was abolished by RAGE siRNA treatment. Thus, the induction of Smad7 by the AGE-RAGE interaction limits the development of pulmonary fibrosis by inhibiting TGF-β-dependent signaling in AECs.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-000088.2011.43.9.004
ISSN:1226-3613
2092-6413
2092-6413
DOI:10.3858/emm.2011.43.9.059